SDHA and non-small cell lung carcinoma: Pull-down assays using recombinant SDHA (His-tagged SDHA) and NSCLC cell lysates further confirmed the minimal impact of gracillin treatment on the assembly of CII subunits (Supplementary Fig. 4c).